Liver Diseases  >>  eplerenone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
eplerenone / Generic mfg.
NCT01801228 / 2011-001264-22: Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects

Withdrawn
2
0
Europe
Eplerenone
Emma Nilsson, Göteborg University, Uppsala University Hospital, Karolinska University Hospital, University Hospital, Linkoeping, University Hospital, Umeå, Region Örebro County
Ascites, Cirrhosis
10/15
10/15

Download Options